1 / 31

Can we prevent infection after an exposure? The world of post-exposure prophylaxis (PEP)

Can we prevent infection after an exposure? The world of post-exposure prophylaxis (PEP). James Wilton Project Coordinator Biomedical Science of HIV Prevention jwilton@catie.ca. HIV/AIDS in Canada. Number of people living with HIV 57,000 in 2005 65,000 in 2008

lok
Download Presentation

Can we prevent infection after an exposure? The world of post-exposure prophylaxis (PEP)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Can we prevent infection after an exposure? The world of post-exposure prophylaxis (PEP) James Wilton Project Coordinator Biomedical Science of HIV Prevention jwilton@catie.ca

  2. HIV/AIDS in Canada Number of people living with HIV 57,000 in 2005 65,000 in 2008 2,200 to 4,200 infected in 2005 2,300 to 4,300 infected in 2008 MSM (44%) People who use injection drugs (17%) Women (26%) Aboriginal (12.5%) 2 2 Source: Public Health Agency of Canada

  3. 3 Improving HIV prevention • Do better with the strategies that we already have • Develop new biomedical technologies to prevent HIV • Adopt a more comprehensive approach to HIV/AIDS prevention

  4. What is post-exposure prophylaxis (PEP)? • Post  After • Exposure  When a fluid containing HIV comes into contact with mucous membranes or non-intact skin • Prophylaxis  An action taken to prevent infection or disease

  5. What is PEP to prevent HIV infection? The use of a combination of antiretrovirals by HIV-negative individuals for a short period of time after a suspected or known exposure to HIV Must be started as soon as possible but within 48-72 hours after the exposure Must be taken everyday for 28 days Must avoid additional exposures while taking PEP Types of exposures Occupational Non-occupational 5 5

  6. Occupational vs. non-occupational exposures Occupational • Work-related exposures to HIV • Needle-stick injuries • Sharp objects • “Standard of care” Non-occupational (nPEP) • Exposures outside of the workplace • Non-consensual sex • Consensual sex • Needle sharing • Not “standard of care”

  7. Does PEP work? • No randomized controlled studies • Observational studies • Studies with control groups • Evaluations of PEP programs • Indirect evidence • Non-human primate (monkey) studies • Prevention of mother-to-child transmission

  8. How does PEP work? • Infection does not occur instantly after an exposure to HIV • The virus needs to spread throughout the body • This may take up to 3 days after the exposure • The “window of opportunity” for PEP • The brief period of time - after an exposure - where infection has not yet occurred • During this time, PEP may be able to stop HIV from causing an infection 8 8

  9. How well does PEP work? We don’t know how protective PEP is We know it is not 100% protective People have become infected despite using PEP Protection likely depends on: Starting PEP quickly Being adherent The risk of transmission from the exposure Avoiding additional exposures The number and type of antiretrovirals used 9 9

  10. Does occupational PEP work? • Study details • 712 healthcare workers exposed to HIV-infected blood • Study findings • 256 did use PEP • 9 became infected • 456 did not use PEP • 24 became infected PEP reduced the risk of HIV transmission by 81%

  11. Does non-occupational PEP work? • Study details • 200 gay men in Brazil given a 4-day starter-pack of PEP • Followed for over 2 years • Study findings • 68 men did use PEP after a high risk exposure • 1 became infected • 86 men did not use PEP after a high risk exposure • 10 became infected Study did not calculate effectiveness of nPEP

  12. Failure of nPEP to prevent infection is rare It is difficult to interpret how protective PEP is… • Would people have remained uninfected without using PEP? • Among those who became infected, was PEP used correctly? 12

  13. What’s involved in taking PEP? • Assessment • Counseling • Prescription • Follow-up

  14. What’s involved in taking PEP? Assessment Was the exposure within the last 72 hours? Is the exposed person HIV-negative? Was the exposure high-risk? What activity led to the exposure? What was the HIV status of the source person? Counseling Prescription Follow-up 14

  15. Guidelines for non-occupational PEP • When is PEP recommended? • Example, the CDC nPEP guidelines • Is there a substantial risk from the activity? • No  PEP not recommended • If yes, was the exposure to someone who was HIV-positive? • No  PEP not recommended • Unknown  Case-by-case basis • Yes  PEP recommended

  16. What’s involved in taking PEP? Assessment Counseling What are the risks and benefits of starting PEP? Is the exposed person ready to start PEP? Adherence and risk-reduction counseling Prescription Follow-up 16

  17. What’s involved in taking PEP? Assessment Counseling Prescription What antiretrovirals? How many? Starter-packs Follow-up 17

  18. Guidelines for non-occupational PEP Barber and Benn 2010 NRTI = nucleoside reverse transcriptase inhibitor NNRTI = non-nucleoside reverse transcriptase inhibitor PI = protease inhibitor Truvada = tenofovir + emtricitabine Kaletra = Lopinavir 18

  19. What’s involved in taking PEP? Assessment Counseling Prescription Follow-up Ongoing risk-reduction and adherence counseling Monitoring/management of side-effects and toxicity HIV testing 19

  20. Why do so few people use nPEP in Canada? People may not think they are at risk Lack of national and provincial guidelines Use of nPEP is not promoted Only available in some emergency departments and urgent care clinics Cost is only covered by some provincial and private insurance plans Side-effects, adherence, monitoring, counseling 20 20 20

  21. Why is there reluctance to make nPEP more widely available? • Feasibility • Cost-effectiveness • Risk compensation

  22. Why is there reluctance to make nPEP more widely available? • Feasibility • Research suggests that nPEP programs are feasible but challenges exists • Cost-effectiveness • Research suggests that targeted nPEP programs are cost-effective • Risk compensation • Research shows that there is little evidence of risk compensation 22

  23. Enhancing the potential benefit of PEP • Access to PEP provides an opportunity to offer additional services to people at high risk of infection • Research study • Study details • In addition to PEP, participants received either: • Standard risk-reduction counseling (2-sessions) • Enhanced risk-reduction counseling (5-sessions) • Participants followed for a year after initiating PEP • Study findings • Standard counseling  12.3% became infected • Enhanced counseling  2.4% became infected • Combining PEP with enhanced risk-reduction counseling can make it a more effective prevention tool

  24. A comprehensive approach to PEP • Integration into a comprehensive prevention program • Targeted outreach and educational campaigns • Prevention, care and support services • Adherence counseling and support • Risk-reduction counseling • Psychological counseling and trauma support • Mental health and addiction services • Advocacy to improve access

  25. Clinique l’Actuel: 9 years experience with nPEP • Sexual health clinic in Montreal, Quebec • Over 1,139 consultations • Prescribed to over 900 people • Majority of PEP users are gay men • 80% first time using PEP • Average time to consultation after exposure - 29 hours • Challenges • 68% complained of side-effects • 50% completed follow-up • 6 HIV infections • Many reported ongoing exposures

  26. CATIE’s Programming Connection

  27. CATIE Resources: PEP factsheet and article

  28. 30

  29. Thank you!

More Related